Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Featured NewsNovartis provides update on Phase III STAND trial assessing crizanlizumab
Featured NewsWorld Economic Forum 2023
Featured NewsNovartis shares strategy insights and highlights key pipeline catalysts at JP Morgan Healthcare Conference 2023
Featured NewsZolgensma Global Managed Access Program in 2023